Neurocentrx Pharma Limited (registration number SC454814) is a private limited company established on 2013-07-18 originating in Scotland. The enterprise has its registered office at C/O Morton Fraser Llp 2 Lister Square, Quartermile Two, Edinburgh EH3 9GL. Neurocentrx Pharma Limited is operating under Standard Industrial Classification: 72110 - "research and experimental development on biotechnology".

Company details

Name Neurocentrx Pharma Limited
Number SC454814
Date of Incorporation: 18th July 2013
End of financial year: 31 October
Address: C/o Morton Fraser Llp 2 Lister Square, Quartermile Two, Edinburgh, EH3 9GL
SIC code: 72110 - Research and experimental development on biotechnology

When it comes to the 3 directors that can be found in this particular business, we can name: Graeme D. (in the company from 16 June 2023), Fraser L. (appointment date: 29 July 2015), Ronald L. (appointed on 07 January 2014). The official register reports 2 persons of significant control, namely: Equity Gap Limited can be found at St. Vincent Street, G2 5RZ Glasgow. The corporate PSC owns 1/2 or less of shares, 1/2 or less of voting rights. Fraser L. has substantial control or influence.

Directors

Accounts data

Date of Accounts 2016-10-31 2017-10-31 2019-10-31 2020-10-31 2021-10-31 2022-10-31
Current Assets 83,336 154,189 48,209 11,160 67,049 1,155,167
Fixed Assets 87,121 81,691 33,424 30,444 27,195 27,761
Total Assets Less Current Liabilities - - - 15,019 -178,120 1,107,224

People with significant control

Equity Gap Limited
6 April 2016 - 12 November 2019
Address 302 St Vincent Street St. Vincent Street, Glasgow, G2 5RZ, Scotland
Legal authority Companies Act 2006
Legal form Limited Company
Country registered Scotland
Place registered Scotland
Registration number Sc378060
Nature of control: 25-50% voting rights
25-50% shares
Fraser L.
6 April 2016 - 6 April 2016
Nature of control: significiant influence or control

Filings

Categories:
Accounts Address Annual return Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
(AP01) New director was appointed on 16th June 2023
filed on: 20th, June 2023 | officers
Free Download (2 pages)